Waverunner
Senior Member
- Messages
- 1,079
Interesting interview about new approaches in antiviral therapy.
http://www.medscape.com/viewarticle/773823
Guy S. Salvesen, PhD: Hello. I am Dr. Guy Salvesen, Program Director of the NCI-designated Cancer Center at Sanford-Burnham Medical Research Institute. Welcome to this segment of Developments to Watch from Sanford-Burnham and Medscape.
Joining me today is my colleague Dr. Sumit Chanda, Associate Professor of the Infectious and Inflammatory Disease Center. Today's program will focus on key research efforts in identifying novel targets for antiviral therapies and how this research will affect clinical practice.
Thank you for joining us, Sumit.
Sumit K. Chanda, PhD: Thank you for having me. [Please click the link for the full interview]]
http://www.medscape.com/viewarticle/773823
Guy S. Salvesen, PhD: Hello. I am Dr. Guy Salvesen, Program Director of the NCI-designated Cancer Center at Sanford-Burnham Medical Research Institute. Welcome to this segment of Developments to Watch from Sanford-Burnham and Medscape.
Joining me today is my colleague Dr. Sumit Chanda, Associate Professor of the Infectious and Inflammatory Disease Center. Today's program will focus on key research efforts in identifying novel targets for antiviral therapies and how this research will affect clinical practice.
Thank you for joining us, Sumit.
Sumit K. Chanda, PhD: Thank you for having me. [Please click the link for the full interview]]